Attenuation of morphine dependence and withdrawal by glycineB site antagonists in rats

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 1, 2001, Pages 157-161

  Kotlińska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

5,7 DCKA; GlycineB site antagonists; L 701,324; MK801; Morphine dependence and withdrawal

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; DIZOCILPINE; MORPHINE; NALOXONE; 5,7-DICHLOROKYNURENIC ACID; AMINO ACID RECEPTOR AFFECTING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; DRUG DERIVATIVE; GLYCINE RECEPTOR; KYNURENIC ACID; NARCOTIC AGENT; NARCOTIC ANTAGONIST; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG USE; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; WET DOG SHAKES; WITHDRAWAL SYNDROME; ANIMAL; ANIMAL BEHAVIOR; DRUG IMPLANT; RAT STRAIN;

CANIS FAMILIARIS; RATTUS NORVEGICUS;

ANIMAL; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE AGENTS; KYNURENIC ACID; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, GLYCINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0035085010     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00443-3     Document Type: Article

References (41)

1. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: An in vivo microdialysis study
2. Follow up study of 105 patients who left treatment
3. Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex
4. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats
5. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents
6. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex
7. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylocholine efflux in morphine-dependent rats
8. Excitatory amino acid receptor antagonists and naloxone-precipitated syndrome in morphine-dependent mice
9. A study of the dose dependency of a glycine receptor antagonist in focal ischemia
10. Effect of NMDA-insensitive and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning
11. Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors
12. Glycine and N-methyl-D-aspartate receptors: Physiological significance and possible therapeutic applications
13. Glutamate in CNS disorders: A revived target for drug development?
14. Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex: A review
15. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence
16. Naloxone-precipitated κ-opioid receptor agonist withdrawal increases glutamate levels in rat locus coeruleus
17. L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM
18. Glycine potentiates the NMDA response in cultured mouse brain neurons
19. L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats
20. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist
21. A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324
22. Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats
23. Effects of MK801 on morphine physical dependence: Attenuation and intensification
24. 3′-(Arylmethyl)- and 3′-(Aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site on the NMDA receptor
25. Continuous co-administration of dextromethorphan or MK-801 with morphine: Attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance
26. Addiction: Brain mechanisms and their treatment implications
27. Non-competitive NMDA antagonists acting on the glycine site
28. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by NMDA receptor antagonist, memantine
29. Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward
30. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists
31. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: Tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors
32. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal
33. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs
34. Direct evidence for a role of glutamate in the expression of opioid withdrawal syndrome
35. Role of glutamate in the locus coeruleus during opiate withdrawal and effects of H-7, protein kinase inhibitor, on the action of glutamate in rats
36. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK801
37. Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence
38. Simultaneous quantitative assessment of morphine tolerance and physical dependence
39. The behavioral pharmacology of NMDA receptor antagonists
40. Opiate reward: Sites and substances
41. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat